Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)

Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)

Background: Cyclin-dependent kinase (CDK) 4/6 inhibitors have remarkably improved the survival outcome in hormone-receptor-positive (HR+)/human epidermal growth factor-2-negative (HER2-) metastatic breast cancer (mBC). Although PALOMA-2 has met its primary outcome, overall survival (OS) was relative...

Full description

Saved in:
Bibliographic Details
Main Authors: Jieun Lee, Dae-Won Lee, Min Hwan Kim, Jee Hung Kim, Ju Won Kim, Jae-Ho Byun, Kyoung Eun Lee, Myoung Joo Kang, Su-Jin Koh, Soojung Hong, Hye Sung Won, Han Jo Kim, In Hae Park, Seong Hoon Shin, Sun Kyung Baek, Seul-Gi Kim, Sung Ae Koh, Joo Young Jung, Ji-Yeon Kim, Gun Min Kim, Kabsoo Shin, In Sook Woo, Hyun Seon Kim, Seock-Ah Im, Yeon Hee Park
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Breast
Subjects:
Hormone receptor–positive breast cancer
Palbociclib
Real-world data
Korea
Asia
Online Access:http://www.sciencedirect.com/science/article/pii/S096097762500517X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S096097762500517X

Similar Items